The investigations center on whether the proposed deal terms unfairly favor insiders or inadvertently block superior bids from alternative buyers. For MarketAxess Holdings Inc., the firm is examining the $167.00 per share cash offer from Intercontinental Exchange. Meanwhile, Sanara MedTech Inc. shareholders are facing a complex deal structure involving $33.00 in cash and 0.4735 shares of MiMedx common stock per share held.
Halper Sadeh Launches Investigations into Four Corporate Mergers
Law firm Halper Sadeh LLC is scrutinizing four pending acquisitions, questioning whether shareholders of MarketAxess, Sanara MedTech, Forte Biosciences, and Luxfer Holdings are receiving adequate value. The firm is investigating potential breaches of fiduciary duty and securities law violations that may have surfaced during these high-stakes buyout negotiations.
Forte Biosciences, Inc. is under review regarding its $77.00 per share cash sale to argenx, and Luxfer Holdings PLC is being scrutinized over its $17.37 per share cash acquisition by affiliates of Wynnchurch Capital. Halper Sadeh LLC indicates it may pursue litigation to seek higher consideration or improved disclosures for investors. The firm operates on a contingent fee basis for these matters, asserting that such legal interventions are necessary to protect global investors from potential corporate misconduct.
Comments (0)
No comments yet. Be the first!